Hana Safah, MD, performed an autologous bone marrow transplant on Jan. 22, marking a milestone for Our Lady of the Lake Cancer Institute’s newest heme-malignancy cell therapy program.
Autologous transplants are used to treat common blood cancers, such as leukemia, lymphoma, and myeloma. This type of transplant involves the patient receiving their own stem cells after chemotherapy.